Release test results
99.753%HPLC purity · meets ≥ 99.5% spec
Mass-spec identityConfirmed · 10.03 mg
Related impurities (total)0.247%
Endotoxin<1.0 EU/mg
HPLC retention time6.22 min
MethodHPLC + LC-MS
ResultPass · meets spec
Lot record
CompoundAOD-9604
Presentation10 MG
Lot numberRGX-26-AOD-771
COA numberNS-2026-05133
Test date23 Apr 2026
Release date26 Apr 2026
Independent labNordicstar Labs
StatusSuperseded
AOD-9604 — lot history
| Lot | Presentation | Tested | HPLC purity | Status |
|---|---|---|---|---|
| RGX-26-AOD-1028 | 5 MG | Jul 25, 2026 | 99.647% | Current |
| RGX-26-AOD-1029 | 10 MG | Jul 24, 2026 | 99.624% | Current |
| RGX-26-AOD-771 this lot | 10 MG | Apr 23, 2026 | 99.753% | Superseded |
| RGX-26-AOD-772 | 5 MG | Apr 22, 2026 | 99.608% | Superseded |
| RGX-26-AOD-672 | 5 MG | Jan 25, 2026 | 99.715% | Superseded |
| RGX-26-AOD-671 | 10 MG | Jan 18, 2026 | 99.722% | Superseded |
!
Research use only
This lot record documents a research compound sold for laboratory use only — not for human or animal consumption. Results are as tested by Nordicstar Labs; retained samples are archived for five years. Research Use Agreement →